How should a beauty or wellness ecommerce brand govern AI product recommendations?

AI product recommendations for beauty and wellness should be governed as controlled commercial guidance, not open-ended health advice. Use an approved product-and-claims source, classify products and shopper questions by risk, apply explicit eligibility rules, show relevant directions and warnings, abstain when evidence or context is missing, and log every answer for review. The brand remains responsible for the claims its assistant communicates.

Start by defining what the assistant is allowed to say

The assistant should help a shopper choose among products using approved facts; it should not diagnose a condition, promise a treatment outcome, or improvise medical advice. Write this boundary into the assistant’s operating policy before connecting a catalog.

A useful policy separates four answer types:

Answer type	What the assistant may do	What it should not do
Product fact	State an ingredient, format, size, listed benefit, or approved use exactly as supported by the source	Add a stronger benefit or imply a result the source does not support
Merchandising recommendation	Compare eligible products against stated preferences such as skin feel, routine step, or product format	Infer suitability from a diagnosis, protected health information, or an unstated condition
Usage guidance	Repeat approved label or product-page directions and material warnings	Create a new dosage, frequency, combination, or duration
Health or safety question	Give a narrow, sourced warning and direct the shopper to a qualified professional or the label where appropriate	Decide whether a product is safe for a person with a condition, pregnancy, medication, allergy, or adverse reaction

This distinction matters because the same words can change a product’s regulatory status. The FDA explains that a product intended to treat or prevent disease is a drug under US law, even if it affects appearance. It also notes that “sunscreen” or similar sun-protection wording generally makes a product subject to drug or drug/cosmetic regulation.

Do not let a conversational answer quietly turn a cosmetic claim into a therapeutic one. Route any proposed claim that mentions treating, curing, preventing, healing, reversing, or clinically managing a condition to regulatory or legal review before it enters the approved source.

Build a claim and ingredient source of truth

An AI assistant is only as governable as the product data behind it. Create a versioned record for every product, variant, market, and claim rather than relying on a product description as the only control.

At minimum, store:

Product classification by market: cosmetic, supplement, drug, device, food, or another applicable category
Full ingredient list and the source and date of the list
Approved product name, variant, size, and intended use
Permitted claims, exact wording, market, evidence owner, and review date
Required warnings, contraindication language, patch-test or sun-exposure directions where applicable
Directions for use, frequency, amount, storage, and age or audience limitations when supplied by the label
Prohibited claims and phrases, including stronger paraphrases of approved language
Inventory, availability, and regional formulation differences
A link or reference to the authoritative label, product page, or substantiation record

Give sources an explicit order of authority. For example, a current regulatory-approved label or market-specific product record should outrank marketing copy, which should outrank reviews and shopper-generated text. Reviews can reveal questions and experiences, but they should not authorize an ingredient claim or safety conclusion.

The FTC’s Health Products Compliance Guidance says advertisers need adequate substantiation before disseminating objective claims, including claims conveyed by implication. It also says health benefits and safety claims generally require competent and reliable scientific evidence. Treat a generated paraphrase as a new presentation of the claim, not as a harmless rewrite.

Classify shopper questions by risk

Risk classification should determine whether the assistant can answer, recommend, warn, or abstain. A simple keyword blocklist is not enough: “Can I use this every day?” may be routine for one product and high-risk for another.

Use a decision table that combines the product, the requested action, and the shopper’s context:

Risk level	Typical question	Controlled response
Lower	“Which cleanser is fragrance-free?”	Answer from the current product record and identify the product used for the comparison
Moderate	“Can I use this exfoliant with my current routine?”	Repeat approved directions and any documented compatibility warning; avoid inventing a combination rule
High	“Is this safe during pregnancy or with my medication?”	Do not make an individualized safety determination; direct the shopper to a clinician, pharmacist, or authoritative label and offer only verified product information
Urgent	“I have swelling, trouble breathing, or a severe reaction”	Stop selling guidance and direct the person to urgent medical help or local emergency services as appropriate

Maintain a separate safety-intent route for allergies, adverse reactions, pregnancy, children, ingestion, eyes, broken skin, and diagnosed conditions. The route should be triggered by meaning and context, not only exact words.

An “unknown” value must never be treated as “safe,” “free from,” or “compatible.” If the ingredient list is missing, the formulation differs by region, or two sources conflict, the assistant should say that it cannot verify the answer and point to the current label or a human team.

Make recommendations rule-based and explainable

The recommendation layer should filter products before the language model explains them. Rules should eliminate ineligible products first, then rank the remaining products using explicit shopper preferences.

A safe sequence is:

Identify the shopper’s stated goal, format preference, market, and relevant routine step.
Apply hard exclusions from the product and safety records.
Check stock, variant, age, and market eligibility.
Rank only products that pass those checks.
Generate an explanation from approved attributes and claims.
Attach the product source and repeat any material direction or warning.

Keep hard safety constraints separate from soft merchandising preferences. “No fragrance” can be a catalog filter if the brand has defined what that means. “Good for eczema” is a health-related claim that needs a different review path and should not be inferred from reviews, ingredients, or a shopper’s diagnosis.

Every recommendation should answer three questions visibly:

Why this product? Name the shopper preference and the approved product attribute that matched it.
What should I know? Show the relevant ingredient fact, direction, limitation, or warning.
What is not known? State when the available product record cannot answer the shopper’s question.

For EU cosmetics, claims require particular discipline. Commission Regulation (EU) No 655/2013 applies to explicit and implicit claims in cosmetic product labelling, market availability, and advertising, with common criteria intended to protect users from misleading claims. A recommendation explanation is still customer-facing commercial communication; it should not escape claim review because it was generated conversationally.

Govern contraindications and usage guidance as controlled content

Contraindications and usage guidance should come from approved, market-specific content and appear when the shopper’s question or selected product makes them relevant. They should not be assembled from general knowledge at response time.

For each warning, define:

The trigger: product, ingredient, use area, audience, question type, or reported symptom
The exact approved wording or a tightly bounded template
The market and formulation to which it applies
Whether it must appear before a recommendation or only with usage instructions
The escalation destination: label, support specialist, pharmacist, clinician, or emergency service
The owner and next review date

For example, FDA guidance for topically applied cosmetics containing alpha hydroxy acids recommends a sunburn alert covering increased sun sensitivity, sunscreen, protective clothing, and limiting sun exposure. That kind of warning should be treated as structured, required content for the applicable products—not left to an assistant to summarize from memory. See the FDA AHA labeling guidance.

Avoid expanding a warning into a personalized medical conclusion. “The label advises limiting sun exposure” is different from “this product is safe for your photosensitivity.” The first reports controlled guidance; the second makes an individualized safety judgment.

Add abstention, escalation, and human review

A compliant assistant needs permission to stop. A confident answer is not a successful answer if the underlying record is incomplete or the question requires professional judgment.

Define abstention conditions in plain operational language:

No approved source for the ingredient, claim, direction, or warning
Conflicting product records or uncertain regional formulation
A request for diagnosis, treatment, prevention, or individualized safety advice
A question involving medication, pregnancy, a child, severe allergy, ingestion, or an adverse reaction
A request to combine products where the brand has no approved compatibility guidance
A request to make the claim stronger, more certain, or more clinical

The response should explain the limit without sounding evasive: identify what can be verified, say what cannot be determined, provide the authoritative next step, and offer a human handoff where available. Do not ask the shopper to rely on a disclaimer while still giving the prohibited recommendation.

Log every answer and test the failure modes

Auditability requires more than storing thumbs-up and thumbs-down feedback. Retain the question, market, product and variant shown, source versions, rules triggered, answer, warnings displayed, escalation decision, and timestamp, subject to applicable privacy requirements.

Test before launch with a red-team set that includes:

Ingredient misspellings, synonyms, and incomplete ingredient questions
“Free from” requests where the catalog value is unknown
Pregnancy, medication, allergy, child, and diagnosed-condition questions
Requests to treat acne, eczema, rosacea, hair loss, pigmentation, or another condition
Routine combinations and repeated-use questions
Region-specific formulations, translated claims, and out-of-stock variants
Reviews that make unsupported efficacy or safety claims
Prompt attempts to override the assistant’s policy or reveal hidden instructions

Score each scenario against a written expected action: answer, recommend, warn, abstain, or escalate. Re-run the set whenever a product record, claim, formulation, policy, or model configuration changes.

After launch, sample conversations by risk category rather than reviewing only conversions. A rising volume of “unknown ingredient” or “can I combine” questions may indicate missing catalog content or unclear product pages. Anagram describes its Site Agent as helping shoppers with conversational product support while they compare and decide, and its broader workflow includes learning from shopper questions. That makes question analysis useful for finding governance gaps—but the compliance owner still needs to approve the source and the corrective action.

Use Anagram as the engagement and learning layer, not the compliance owner

Anagram’s public site describes a branded Site Agent for product questions and recommendations, alongside shopper-question insights and AI Visibility monitoring. Its published guidance recommends trusted sources, narrow launches, answer guardrails, and escalation for uncertain answers.

For a beauty or wellness pilot, keep the scope bounded: start with a small set of products, approved catalog attributes, non-therapeutic shopping questions, and explicit escalation paths. Before expanding, verify how the implementation supports your requirements for source versioning, regional content, rule changes, conversation logs, access controls, retention, and human review.

Its AI Visibility product monitors how a brand appears in ChatGPT, competitors, and citation sources. That can help a team identify where public product language creates confusion or where shoppers arrive with unsupported expectations. It does not replace claim substantiation, regulatory review, label control, or medical escalation.

The governing principle is simple: let the assistant be conversational about verified shopping facts, deterministic about eligibility and warnings, and explicit about its limits. That protects the shopper while giving the ecommerce team a reviewable way to improve recommendations over time.